Why Is Azitra (AZTR) Stock Up 315% Today?

Azitra (NYSEMKT:AZTR) stock is taking off on Tuesday after the early-stage biopharmaceutical company provided investors with updates on its patents.This covers the company’s filaggrin-secreting strain of Staphylococcus epidermidis. A patent was issued to it on July 16 U.S. Patent and Trademark Office (USPTO). That includes future potential pipeline candidates for indications including atopic dermatitis.On top of this, Azitra announced three newly allowed patents in the U.S., Canada, and China. The U.S. pate ...